GUIDELINES OF CARE FOR THE MANAGEMENT OF ATOPIC DERMATITIS

By R. Sidbury, D. Davis, D. Cohen, K. Cordoro, T. Berger, J. Bergman, S. Chamlin, K. Cooper, S. Feldman, J. Hanifin and 13 more. Journal of American Academy of Dermatology, 2014

910 citations recorded by the source corpus.

Atopic dermatitis (AD) is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2-3% of adults. This guideline addresses important clinical questions that arise in AD management and care, providing recommendations based on the available evidence. In this third of four sections, treatment of AD with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.

Subfields: Dermatology, Immunology and Allergy, Physiology

View Paper: https://www.semanticscholar.org/paper/fd12dde1ade742cbf463ce19f44faeaf85c6d65b

Citations in the corpus

• Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer (2023, neutral): “Existing therapies for AD relieve the symptoms but cannot delay disease progression, and all of these therapies have limitations in clinical applications.(245,246) The pathogenesis of AD has a multifactorial origin and is considered to predominantly result from T helper 2 Fig.”